Established in 2000 as ClinMedica Research and acquired by Velocity Clinical Research in 2023, the experienced team at the dedicated Velocity research site in Skierniewice conducts phase 2-4 clinical trials across a wide range of indications. The Skierniewice site is the largest clinical research facility in the region and specializes in cardiology, dermatology, pulmonology, endocrinology, population-based vaccine studies, metabolic diseases, diabetology, gastroenterology, and more.
Velocity Skierniewice is known for an excellent reputation, quality recruitment and exceptional patient care. It is recognized as one of the best research facilities in the country by sponsors and contract research organizations (CROs).